Joop C. van Oene - Concepedia

Author

Joop C. van Oene

Also Known As

J C van Oene, J. C. Van Oene, J. C. van Oene, J.C. VAN OENE, J.C. Van Oene, J.C. van Oene, Joop C van Oene, Joop C. Van Oene, Joop C. van Oene

Publications

808

Citations

H-Index

Concepts

All Affiliations

Janssen (Netherlands)University of Groningen Janssen (Belgium)Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona

About

Joop C. van Oene is an author at Janssen (Netherlands) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	477
2	Social Sciences	5	5	123
3	Biochemistry	1	1	39
4	Molecular Biology	1	1	71
5	Neurology	1	1	150

Joop C. van Oene

Publications

780

Citations

H-Index

Page 1

	Year	Citations
The influence of cisapride and clarithromycin on QT intervals in healthy volunteers Aernout D. van Haarst, Gerben A. E. van't Klooster, Joop van Gerven, Clinical Pharmacology & Therapeutics	1998	151
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial Alistair Burns, Roberto Bernabei, Roger Bullock, The Lancet Neurology Neurodegenerative DiseasesSevere AlzheimerAlzheimer's DiseaseMedicineDouble-blind Trial	2008	150
Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation Cornelius E. J. Sloots, Alexander C. Poen, René Kerstens, Alimentary Pharmacology & Therapeutics	2002	95
[125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor A Sidhu, Joop C. van Oene, Penelope A. Dandridge, European Journal of Pharmacology Molecular PharmacologyMedicineD-1 Dopamine ReceptorReceptor (Biochemistry)Molecular Biology	1986	71
The D1 dopamine receptor: new perspectives John W. Kebabian, Takashi Agui, Joop C. van Oene, Trends in Pharmacological Sciences PsychiatryFunctional SelectivityMedicineNeuropeptide ReceptorNeuropharmacology	1986	70
The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo Joop C. van Oene, Jan B. De Vries, Alan S. Horn Naunyn-Schmiedeberg s Archives of Pharmacology Molecular PharmacologyNeuropsychologyPsychoactive DrugNeurophysiologyMedicine	1984	43
In vivo dopamine autoreceptor selectivity appears to be critically dependent upon the aromatic hydroxyl position in a series of N,N-disubstituted 2-aminotetralins Joop C. van Oene, Jan B. De Vries, Durk Dijkstra, European Journal of Pharmacology N-disubstituted 2-AminotetralinsBiochemistryFunctional SelectivityMedicineAromatic Hydroxyl Position	1984	39
Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate Jan K. Buitelaar, J. J. Sandra Kooij, Josep Antoni Ramos‐Quiroga, Progress in Neuro-Psychopharmacology and Biological Psychiatry AdhdTreatment OutcomePsychiatryPsychotropic MedicationOros® Methylphenidate	2010	37
Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty Patrick W. Serruys, Werner Klein, Jan G.P. Tijssen, RePub (Erasmus University, Rotterdam)	1993	29
Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate Jan K. Buitelaar, Miguel Casas, Alexandra Philipsen, Psychological Medicine	2011	28

Page 1